FZD6 and glioblastoma: Low expression of the transcription factor TCF4 coupled to high levels of FZD6 predict low survival of glioblastoma patients.62 These findings suggest that expression of FZD6, like other stem cell markers, could be potentially used as a prognostic biomarker in different types of human cancer.